Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

20 Biggest Mid-Day Losers For Friday

AMSC, DGII, IESC, IMMR, LPTH, NCMI, ROCK, YELLQ, MFA

  • Ampliphi Biosciences Corp (NYSE: APHB) shares tumbled 58.6 percent to $1.20. AmpliPhi Biosciences disclosed the pricing of its 6.95 million share offering of common stock and warrants.
  • Brightcove Inc (NASDAQ: BCOV) shares dipped 30.8 percent to $6.03 after the company reported a wider-than-expected Q1 loss and issued a weak FY17 forecast. B. Riley downgraded Brightcove from Buy to Neutral.
  • National CineMedia, Inc. (NASDAQ: NCMI) shares dropped 23.8 percent to $8.93. National CineMedia reported a Q1 loss of $5 million. JP Morgan downgraded National CineMedia from Overweight to Neutral, while FBR Capital downgraded the stock from Outperform to Market Perform.
  • Revlon Inc (NYSE: REV) shares fell 23.2 percent to $19.40. Revlon reported a Q1 loss of $0.23 per share on revenue of $594.9 million.
  • ArcBest Corp (NASDAQ: ARCB) shares plunged 20.3 percent to $20.93 as the company posted a wider-than-expected Q1 loss.
  • American Superconductor Corporation (NASDAQ: AMSC) shares declined 16.3 percent to $4.06. AMSC reported a proposed public offering of common stock.
  • Regulus Therapeutics Inc (NASDAQ: RGLS) shares dropped 15.5 percent to $1.44 after the company posted a larger-than-expected loss for its first quarter. The company also disclosed that it has completed dosing of RG-012 in Phase 1 study.
  • YRC Worldwide Inc (NASDAQ: YRCW) fell 14.5 percent to $9.14 as the company posted a wider-than-expected quarterly loss.
  • IES Holdings Inc (NASDAQ: IESC) shares fell 13.2 percent to $17.15. IES Holdings reported Q2 GAAP earnings of $0.02 per share on revenue of $204 million.
  • Digi International Inc. (NASDAQ: DGII) shares declined 13 percent to $10.70 after the company posted downbeat quarterly earnings.
  • Gain Capital Holdings Inc (NYSE: GCAP) dropped 11.4 percent to $6.56 as the company posted weak Q1 results.
  • Immersion Corporation (NASDAQ: IMMR) plunged 10.9 percent to $8.10 on weaker-than-expected Q1 results.
  • Gibraltar Industries Inc (NASDAQ: ROCK) shares declined 10.3 percent to $35.00. Gibraltar reported Q1 profit of $4 million on revenue of $206.6 million. Gibraltar lowered its FY17 earnings guidance.
  • MINDBODY Inc (NASDAQ: MB) dropped 9.7 percent to $25.75. MINDBODY reported Q1 adjusted loss of $0.03 per share on revenue of $42.2 million. Pacific Crest downgraded MINDBODY from Overweight to Sector Weight.
  • Alder Biopharmaceuticals Inc (NASDAQ: ALDR) declined 8.1 percent to $20.05. UBS initiated coverage on Alder Biopharmaceuticals with a Sell rating.
  • LightPath Technologies, Inc. (NASDAQ: LPTH) dropped 8 percent to $2.69. LightPath Technologies posted Q3 net income of $101,000, down from $776,000 in the year-ago quarter.
  • Aceto Corporation (NASDAQ: ACET) share slipped 7.8 percent to $14.39 on downbeat Q3 results.
  • Hercules Capital Inc (NASDAQ: HTGC) fell 4.5 percent to $12.88. Hercules Technology reported a Q1 loss of $5.6 million.
  • MFA Financial, Inc. (NYSE: MFA) declined 3.7 percent to $7.88. MFA Financial reported Q1 earnings of $0.20 per share and announced an offering of 20 million shares.
  • Planet Fitness Inc (NYSE: PLNT) shares fell 3 percent to $20.43. Planet Fitness reported a 16 million share secondary offering of class A common stock by selling stockholders.


Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today